TELA Bio (NASDAQ:TELA – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports. Several other equities analysts also recently issued reports on the stock. Craig Hallum started coverage on shares of TELA Bio […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.